Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast CancerClin. Breast Cancer 2020 Jul 24;[EPub Ahead of Print], M Morimoto, H Toba, M Aoyama, M Nakagawa, H Takechi, T Yoshida, A Tangoku
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.